As global citizens, we work sustainably and responsibly to create a positive impact in the communities where we live and work. We conduct our global business with the utmost integrity and transparency. We support programs, initiatives and organizations that help improve health, expand research opportunities, promote and expand STEM education and deliver basic human services to our communities.
We know that our responsibility goes beyond medicine. We promote health equity globally and strive to increase access to life-saving medicines for populations disproportionately affected by serious diseases and conditions. We achieve this in part through the Bristol Myers Squibb Foundation, which supports community-based programs that promote cancer awareness, screening, care and support among high-risk populations. Bristol Myers Squibb is a global biopharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.
Everything we do is guided by our unwavering dedication to our mission, vision, values and commitment. November 11, November 10, November 01, Science. October 28, Science. Survivorship Today. Emmy winner Sterling K. Brown explores cancer survivorship during a global pandemic. Chairman of the Board, Chief Executive Officer. David V. Ann M. Sandra Leung. Christopher S. New Stories. Bristol Myers Squibb Co has expressed interest in buying autoimmune disease drug developer Aurinia Pharmaceuticals Inc, Bloomberg News reported on Friday, citing people familiar with the matter.
Bristol-Myers Squibb Co will require all its employees working in the United States and Puerto Rico to be fully vaccinated against the coronavirus effective Nov.
Corrects paragraph 1 and 2 to show one patent, not patents. Bristol Myers Squibb Co reported second quarter earnings that topped Wall Street estimates, as sales of flagship cancer treatment Opdivo returned to growth after missing estimates in the previous quarter. Bristol-Myers Squibb Co and Eisai Co on Thursday entered into an agreement to jointly develop and market an experimental cancer drug. Bristol Myers Squibb said on Thursday the U. Food and Drug Administration approved its oral drug Zeposia to treat adults with ulcerative colitis, a chronic inflammatory bowel disease.
An immunotherapy showed for the first time it can help early-stage lung cancer patients survive longer without their disease returning, according to data on Wednesday, a potential turning point for such drugs to be used before tumours spread. An experimental Bristol Myers Squibb drug from a new class of immunotherapy used in combination with its big-selling cancer medicine Opdivo significantly extended the time it took for advanced melanoma to worsen compared with Opdivo alone, according to early data from a Bristol Myers Squibb Co reported lower-than-expected first-quarter profit on Thursday as sales of its high margin cancer drugs Revlimid and Opdivo fell short of Wall Street estimates.
The U. Quote and financial data from Refinitiv.
0コメント